Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability

Translational Oncology(2021)10.1016/j.tranon.2021.101323Source: DataRank Database

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability is a research paper published in Translational Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.71)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Lois Parks ORCID,Kakajan Komurov ORCID,Lisa M. Privette Vinnedge ORCID,Belal A. Muhammad ORCID

Live enrichment

PubMed:34954455 PMC:PMC8718660 OpenAlex:https://openalex.org/W4200474511

NCI NIH HHS

Grant: R01 CA193549

NCI NIH HHS

Grant: R37 CA218072

National Institutes of Health

Grant: 5R01CA193549-02

Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers

National Institutes of Health

Grant: 5R37CA218072-04

Mechanisms coupling DEK to oncogenesis

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.tranon.2021.101323

GOLDhttps://doi.org/10.1016/j.tranon.2021.101323

publisherhttps://doi.org/10.1016/j.tranon.2021.101323

publisherhttps://api.elsevier.com/content/article/PII:S1936523321003144?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936523321003144?httpAccept=text/plain

Fields of Study

Autophagy in Disease and TherapyUbiquitin and proteasome pathwaysEndoplasmic Reticulum Stress and DiseaseMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AutophagyProteasomeBiologyPhenotypeCell biologyUbiquitinTranscription (linguistics)Cancer cellCancer researchIn vitroRNAProtein degradationGeneCancerApoptosisGeneticsProtein HomeostasisProteotoxic StressAggresomesTranscription Elongation Defects (Te(def))Transcription elongation defects (TEdef)Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Original Research

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)